Item 2. Properties
ITEM 2. PROPERTIES
Manufacturing and other operations are conducted in several locations worldwide. The following tables provide certain information about our significant general offices and manufacturing facilities:
Properties Approximate
Owned: Use Total Sq. Ft.
Cavite, Philippines Wafer probe and testing, warehouse, engineering and administrative offices 1,486,000 sq. ft.
Wilmington, MA Corporate headquarters, wafer fabrication, testing, engineering, sales, marketing and administrative offices 826,000 sq. ft.
Chonburi Province, Thailand Wafer probe and testing, warehouse, engineering and administrative offices 744,000 sq. ft.
Limerick, Ireland Wafer fabrication, wafer probe and testing, warehouse and distribution, engineering and administrative offices 708,500 sq. ft.
Penang, Malaysia (1) (2)
Wafer probe and testing, assembly and engineering offices
697,000 sq. ft.
Beaverton, OR Wafer fabrication, engineering and administrative offices 458,000 sq. ft.
San Jose, CA Engineering, sales, marketing and administrative offices 441,000 sq. ft.
Chelmsford, MA Final assembly of certain module and subsystem-level products, testing, engineering and administrative offices 237,000 sq. ft.
Lease
Properties Approximate Termination
Leased: Use Total Sq. Ft. (fiscal year) Renewals
Bangalore, India Engineering and administrative offices 175,000 sq. ft. 2027 1, five-yr.
period
Durham, NC
Testing, engineering, and administrative offices
156,000 sq. ft. 2035 2, five-yr. periods
(1) Leases on the land used for this owned facility expire in 2054 through 2057.
(2) For further information concerning our held for sale assets at the Penang, Malaysia facility, see Note 2e, Property, Plant and Equipment, of the Notes to Consolidated Financial Statements contained in Part II, Item 8 of this Annual Report on Form 10-K.
In addition to the properties listed in the above tables, we also own or lease a number of other facilities in various locations in the United States and internationally that are used for manufacturing, engineering, sales and marketing and administration activities. Leases for these leased facilities expire at various dates through the year 2039. We do not anticipate experiencing significant difficulty in retaining occupancy of any of our facilities through lease renewals prior to expiration or through month-to-month occupancy, or in replacing them with equivalent facilities. For information concerning our obligations under all operating leases, see Note 7, Leases , of the Notes to Consolidated Financial Statements contained in Part II, Item 8 of this Annual Report on Form 10-K.
27
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.